Boss of Open Orphan volunteers for Covid-19 drug trial
Executive chairman of the Irish drug testing firm, Cathal Friel, wants to be part of study which involves being infected by the virus
The head of Open Orphan, the Irish drug trials and testing company, has said he has volunteered to be infected with a dose of Covid-19 as part of a human study into the virus.
Open Orphan’s subsidiary hVIVO won a £40 million (€44 million) contract with the British government last week which will see it conduct what is termed a human challenge trial, that will involve volunteers being given a strain of Covid-19 to study...
Subscribe from just €1 for the first month!
What's Included
With any subscription you will have access to
-
Unlimited multi-device access to our iPad, iPhone and Android Apps
-
Unlimited access to our eReader library
-
Exclusive daily insight and opinion seven days a week
-
Create alerts to never miss a subject that matters to you
-
Get access to exclusive offers for subscribers on gifts and experiences
-
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Related Stories
Former Bank of Ireland CEO appointed chair of Irish-owned ethanol company
Clonbio operates the largest bio-ethanol refinery in Europe producing over 500 million litres of bio-ethanol fuel every year.
Paul McCann to join Ergo as chief executive
The former managing partner of Grant Thornton will join Ergo later this year when his role as interim chief financial officer at Permanent TSB concludes
